URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Louis Constine

Concepts (482)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hodgkin Disease
38
1982
152
6.910
Why?
Neoplasms, Second Primary
17
2000
124
4.140
Why?
Radiotherapy
31
1981
179
4.070
Why?
Radiation Injuries
21
1988
123
3.850
Why?
Neoplasms
21
1981
701
2.710
Why?
Survivors
17
1993
112
2.340
Why?
Sarcoma
5
1992
59
2.250
Why?
Antineoplastic Combined Chemotherapy Protocols
16
1985
409
2.140
Why?
Cardiovascular Diseases
11
2003
250
1.830
Why?
Neoplasms, Radiation-Induced
11
1995
80
1.630
Why?
Child
52
1973
3897
1.430
Why?
Neoplasm Recurrence, Local
8
1995
272
1.400
Why?
Stem Cell Transplantation
3
1999
108
1.390
Why?
Soft Tissue Neoplasms
3
1992
41
1.350
Why?
Radiotherapy Dosage
22
1981
185
1.330
Why?
Humans
116
1973
35000
1.300
Why?
Lung Neoplasms
6
1985
422
1.290
Why?
Aging
5
2006
692
1.210
Why?
Adolescent
45
1981
4513
1.200
Why?
Combined Modality Therapy
24
1984
459
1.130
Why?
Adult
51
1981
10906
1.120
Why?
Breast Neoplasms
8
2008
660
0.990
Why?
Bone Marrow Transplantation
8
1984
189
0.960
Why?
Hematopoietic Stem Cell Transplantation
4
1998
124
0.950
Why?
Whole-Body Irradiation
7
1984
78
0.930
Why?
Child, Preschool
31
1973
2452
0.920
Why?
Young Adult
16
2009
1013
0.910
Why?
Heart
5
1995
228
0.890
Why?
Risk Factors
20
1991
2172
0.850
Why?
Radiation Oncology
5
2008
17
0.850
Why?
Female
69
1973
19061
0.840
Why?
Lymphoma, Large B-Cell, Diffuse
2
2009
72
0.800
Why?
Male
57
1973
18870
0.800
Why?
Antineoplastic Agents
11
1985
598
0.790
Why?
Brain Neoplasms
5
1987
254
0.780
Why?
Central Nervous System Neoplasms
2
1999
20
0.750
Why?
Fractures, Spontaneous
1
2010
15
0.720
Why?
Cell Aging
2
2010
53
0.710
Why?
Leg
1
2010
95
0.700
Why?
Incidence
10
1995
644
0.690
Why?
Graft vs Host Disease
3
1999
92
0.690
Why?
Radiosurgery
1
2011
73
0.680
Why?
Bone Density
1
2010
103
0.680
Why?
Cell Transformation, Neoplastic
2
2010
134
0.680
Why?
Middle Aged
30
1987
9461
0.670
Why?
Radiation Tolerance
9
1981
78
0.650
Why?
Anthracyclines
5
2007
17
0.630
Why?
DNA Repair
1
2010
168
0.620
Why?
Heart Diseases
4
1995
132
0.610
Why?
Neoplasm Staging
12
1985
326
0.590
Why?
Aged
19
1987
6986
0.580
Why?
Practice Guidelines as Topic
4
2008
288
0.570
Why?
Dose-Response Relationship, Radiation
14
1984
205
0.570
Why?
Follow-Up Studies
16
1984
1757
0.570
Why?
Tomography, X-Ray Computed
8
1988
729
0.560
Why?
Skin Diseases
1
2008
120
0.560
Why?
Time Factors
15
1982
3047
0.550
Why?
Leukemia, Myeloid, Acute
1
2008
172
0.550
Why?
Stereotaxic Techniques
1
2006
32
0.530
Why?
Radiology
3
1992
29
0.530
Why?
Risk Assessment
8
2004
808
0.530
Why?
Liver Neoplasms
2
2006
149
0.520
Why?
Disease
1
2006
36
0.520
Why?
Infant
13
1981
2102
0.510
Why?
Survival Rate
13
1990
584
0.510
Why?
Survival Analysis
10
1993
575
0.510
Why?
Dose Fractionation
4
2006
57
0.510
Why?
Thyroid Neoplasms
5
1995
64
0.510
Why?
Diagnostic Imaging
5
1995
81
0.500
Why?
Transplantation, Autologous
7
1984
136
0.500
Why?
Glioma
2
1987
92
0.490
Why?
Amifostine
4
1985
25
0.470
Why?
Treatment Outcome
12
1996
2487
0.470
Why?
Bone Marrow
6
1984
282
0.460
Why?
Hypothyroidism
6
1982
39
0.460
Why?
Antibiotics, Antineoplastic
3
1993
51
0.450
Why?
Optic Nerve Neoplasms
1
2003
1
0.440
Why?
Neurofibromatosis 1
1
2003
6
0.440
Why?
Endocrine System Diseases
3
1997
13
0.410
Why?
Salvage Therapy
3
2009
56
0.410
Why?
Recurrence
6
1997
656
0.400
Why?
Thyroid Gland
3
1993
51
0.390
Why?
Medical Oncology
2
1992
40
0.380
Why?
Population Surveillance
4
2001
120
0.370
Why?
Radiation-Protective Agents
3
1986
38
0.370
Why?
Prognosis
9
1996
1030
0.350
Why?
Antibodies, Monoclonal, Murine-Derived
2
2009
124
0.340
Why?
Cyclophosphamide
6
1998
169
0.340
Why?
Models, Statistical
3
2010
222
0.340
Why?
Thymus Gland
2
2010
143
0.340
Why?
Rhabdoid Tumor
1
1999
3
0.330
Why?
Ventriculoperitoneal Shunt
1
1999
11
0.330
Why?
Peritoneal Neoplasms
1
1999
25
0.330
Why?
Pituitary Neoplasms
2
1989
64
0.310
Why?
Hypothalamo-Hypophyseal System
2
1995
50
0.310
Why?
Neoadjuvant Therapy
2
2007
30
0.300
Why?
Sex Factors
7
1975
561
0.300
Why?
Lung Diseases
3
2006
224
0.290
Why?
Age Distribution
4
2010
201
0.290
Why?
Retrospective Studies
8
1985
2167
0.290
Why?
Age Factors
9
1973
1060
0.290
Why?
Organothiophosphorus Compounds
2
1986
8
0.280
Why?
Severity of Illness Index
3
1995
878
0.280
Why?
Models, Biological
4
1988
982
0.280
Why?
Methotrexate
3
1990
73
0.270
Why?
Cell Proliferation
2
2010
480
0.260
Why?
Transplantation, Homologous
4
1999
261
0.260
Why?
Magnetic Resonance Imaging
5
1988
928
0.260
Why?
Rhabdomyosarcoma
1
1995
12
0.260
Why?
Cranial Irradiation
3
1990
13
0.250
Why?
Medulloblastoma
3
1987
17
0.250
Why?
Thyroid Diseases
1
1995
19
0.250
Why?
Cerebellar Neoplasms
3
1987
19
0.250
Why?
Lymphoma, Non-Hodgkin
2
1997
105
0.250
Why?
Fibroblast Growth Factor 2
3
1998
76
0.250
Why?
Siblings
2
2010
35
0.250
Why?
Lymphoma
2
1998
151
0.240
Why?
Clinical Trials as Topic
6
1985
664
0.240
Why?
Doxorubicin
4
1990
102
0.230
Why?
Disease-Free Survival
6
1998
191
0.230
Why?
Head and Neck Neoplasms
1
1995
78
0.230
Why?
Radiation Dosage
6
1993
115
0.230
Why?
Radiotherapy, Adjuvant
3
1998
72
0.220
Why?
Bone Development
2
1987
66
0.220
Why?
Morbidity
2
2009
70
0.210
Why?
Guideline Adherence
2
2010
72
0.210
Why?
Hypothalamus
1
1993
84
0.210
Why?
Pituitary Gland
1
1993
61
0.210
Why?
Gonadal Disorders
1
2012
1
0.210
Why?
Reproductive Health
1
2012
1
0.210
Why?
Gastrointestinal Neoplasms
1
2012
20
0.200
Why?
Hyperprolactinemia
2
1987
5
0.200
Why?
Brain
2
1988
1161
0.200
Why?
Vincristine
3
1990
57
0.200
Why?
Echocardiography
2
1993
202
0.200
Why?
Quality Assurance, Health Care
2
2009
114
0.200
Why?
Carcinoma, Ductal, Breast
2
2008
39
0.200
Why?
United States
7
1992
2511
0.190
Why?
Aged, 80 and over
5
1992
2423
0.190
Why?
Histiocytoma, Malignant Fibrous
1
2011
5
0.190
Why?
Colony-Forming Units Assay
1
1991
37
0.190
Why?
Sarcoma, Synovial
1
2011
7
0.190
Why?
Leiomyosarcoma
1
2011
18
0.190
Why?
Growth Plate
2
2001
114
0.180
Why?
Databases, Factual
2
1999
147
0.180
Why?
Remission Induction
2
1997
155
0.180
Why?
Adiposity
1
2010
9
0.180
Why?
Weight-Bearing
1
2010
41
0.180
Why?
Cytoprotection
1
2010
35
0.180
Why?
Carcinoma, Non-Small-Cell Lung
1
2011
66
0.180
Why?
Predictive Value of Tests
5
1999
579
0.180
Why?
Prednisone
2
1998
178
0.180
Why?
Meta-Analysis as Topic
1
2010
36
0.170
Why?
Information Dissemination
1
2010
24
0.170
Why?
Clinical Protocols
1
2010
102
0.170
Why?
Chronic Disease
2
1991
496
0.170
Why?
Brain Injuries
1
2011
91
0.170
Why?
Interleukin-1
1
1991
204
0.170
Why?
Osteonecrosis
1
2010
23
0.170
Why?
Antibodies, Monoclonal
3
1985
725
0.170
Why?
Testicular Neoplasms
1
2010
52
0.170
Why?
Chemotherapy, Adjuvant
2
1996
85
0.170
Why?
Thyroid Hormones
2
1984
32
0.170
Why?
Infertility
2
2006
22
0.170
Why?
Intelligence
1
1990
104
0.170
Why?
Health Status
1
2012
263
0.170
Why?
Fractures, Bone
1
2010
85
0.160
Why?
Craniopharyngioma
1
1989
3
0.160
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1990
82
0.160
Why?
Homeostasis
1
2010
171
0.160
Why?
Leukemia
2
1999
152
0.160
Why?
DNA Damage
1
2010
168
0.160
Why?
Splenectomy
1
2008
36
0.160
Why?
Abdominal Neoplasms
1
2008
14
0.160
Why?
Analysis of Variance
2
1999
705
0.160
Why?
Carmustine
4
1987
35
0.160
Why?
Neoplasm Metastasis
2
1985
219
0.160
Why?
Biopsy, Fine-Needle
1
2008
21
0.160
Why?
Carcinoid Tumor
1
2008
26
0.150
Why?
Carcinoma in Situ
1
2008
41
0.150
Why?
Quality of Life
3
2005
486
0.150
Why?
Glioblastoma
3
1988
55
0.150
Why?
Adenoma
1
2008
57
0.150
Why?
Statistics as Topic
1
2008
177
0.150
Why?
Etoposide
5
1998
73
0.150
Why?
Biomedical Research
1
2009
132
0.140
Why?
Regeneration
2
1984
59
0.140
Why?
Pediatrics
1
1992
376
0.140
Why?
Razoxane
1
2007
7
0.140
Why?
Patient Care Planning
1
2007
63
0.140
Why?
SEER Program
3
2010
51
0.140
Why?
Chelating Agents
1
2007
65
0.140
Why?
Aging, Premature
1
2006
7
0.140
Why?
Delivery of Health Care
1
2008
136
0.140
Why?
Cohort Studies
4
2007
912
0.130
Why?
Tumor Burden
1
2006
22
0.130
Why?
Radiotherapy, Computer-Assisted
1
2006
14
0.130
Why?
Cartilage
1
1987
125
0.130
Why?
Oxidative Stress
1
2010
330
0.130
Why?
Leukemia, Myeloid
1
2007
115
0.130
Why?
Odds Ratio
3
2010
301
0.130
Why?
Apoptosis
2
2002
782
0.130
Why?
Transplantation Conditioning
2
1999
33
0.130
Why?
Foundations
1
2005
11
0.130
Why?
Myelodysplastic Syndromes
1
2007
129
0.130
Why?
Radiotherapy Planning, Computer-Assisted
3
2008
44
0.120
Why?
Adenocarcinoma
1
2008
431
0.120
Why?
Skin
1
1987
370
0.120
Why?
Nervous System Diseases
1
2006
141
0.120
Why?
Animals
15
1981
15647
0.120
Why?
Thyrotropin
3
1982
29
0.120
Why?
Cardiomyopathies
2
1993
75
0.120
Why?
Puberty, Precocious
2
1995
4
0.110
Why?
Hematopoietic Stem Cells
4
1984
196
0.110
Why?
Ventricular Function, Left
2
1990
88
0.110
Why?
Coronary Disease
2
1995
247
0.110
Why?
Cognition Disorders
1
2007
262
0.110
Why?
Optic Chiasm
1
2003
6
0.110
Why?
Prostatic Neoplasms
2
1985
548
0.110
Why?
Infant, Newborn
5
1981
1772
0.110
Why?
Mediastinum
1
2003
18
0.110
Why?
Stomatitis
2
1999
15
0.110
Why?
Fibrosis
2
1995
60
0.100
Why?
Visual Pathways
1
2003
72
0.100
Why?
Mental Disorders
1
2006
301
0.100
Why?
Myocardial Infarction
3
1996
630
0.100
Why?
Pentoxifylline
1
2002
23
0.100
Why?
Rabbits
4
1984
686
0.100
Why?
Platinum Compounds
2
2010
7
0.100
Why?
European Continental Ancestry Group
2
1996
225
0.100
Why?
Infertility, Male
2
2010
33
0.090
Why?
Transforming Growth Factor beta
2
1998
362
0.090
Why?
Astrocytoma
2
1988
26
0.090
Why?
Growth
1
1981
38
0.090
Why?
Myocardium
2
1995
284
0.090
Why?
Dose-Response Relationship, Drug
4
1987
1085
0.090
Why?
Hyperthyroidism
2
1982
22
0.090
Why?
Coronary Artery Disease
2
2010
85
0.090
Why?
Exercise Test
2
1993
88
0.090
Why?
Chondrocytes
1
2002
220
0.090
Why?
Parenteral Nutrition
1
1999
23
0.080
Why?
Nifedipine
1
1999
33
0.080
Why?
Cytarabine
3
1998
82
0.080
Why?
Ring Chromosomes
1
1999
4
0.080
Why?
Methylprednisolone
1
1999
44
0.080
Why?
Chromosomes, Human, Pair 22
1
1999
11
0.080
Why?
Calcium Signaling
1
2002
180
0.080
Why?
Mouth Mucosa
1
1999
43
0.080
Why?
Models, Animal
2
2010
131
0.080
Why?
Cyclosporine
1
1999
61
0.080
Why?
Case-Control Studies
2
2010
587
0.080
Why?
Calcium Channel Blockers
1
1999
66
0.080
Why?
Research
2
2010
169
0.080
Why?
Pituitary Hormones
2
1995
13
0.080
Why?
Genetic Predisposition to Disease
2
2010
306
0.080
Why?
Bone Neoplasms
2
1985
180
0.080
Why?
Cause of Death
3
1990
155
0.080
Why?
Immunosuppressive Agents
1
1999
200
0.070
Why?
Exercise Tolerance
1
1997
10
0.070
Why?
Diastole
1
1997
26
0.070
Why?
Radiation Pneumonitis
2
2007
37
0.070
Why?
Risk
2
2007
343
0.070
Why?
Neovascularization, Physiologic
1
1998
112
0.070
Why?
Fatigue
2
2007
122
0.070
Why?
Bleomycin
3
1990
44
0.070
Why?
Stroke Volume
1
1997
140
0.070
Why?
Gene Expression Regulation
1
2002
848
0.070
Why?
Reproducibility of Results
2
2008
859
0.070
Why?
Evidence-Based Medicine
2
2004
197
0.060
Why?
Multicenter Studies as Topic
1
1996
126
0.060
Why?
Ploidies
1
1995
18
0.060
Why?
Genes, myc
1
1995
26
0.060
Why?
Drug Resistance, Multiple
1
1995
26
0.060
Why?
Pituitary Hormones, Anterior
1
1995
5
0.060
Why?
Bone and Bones
1
1998
330
0.060
Why?
Pericardium
1
1995
13
0.060
Why?
Genes, Tumor Suppressor
1
1995
49
0.060
Why?
African Continental Ancestry Group
1
1996
116
0.060
Why?
Follicle Stimulating Hormone
1
1995
49
0.060
Why?
Luteinizing Hormone
1
1995
51
0.060
Why?
Growth Hormone
1
1995
103
0.060
Why?
Adrenocorticotropic Hormone
1
1995
70
0.060
Why?
Proportional Hazards Models
2
1996
398
0.060
Why?
Injury Severity Score
1
1995
73
0.060
Why?
Neuroblastoma
2
1985
91
0.060
Why?
Mice
7
1981
5900
0.060
Why?
Prospective Studies
3
1993
1606
0.060
Why?
Cell Cycle
1
1995
247
0.060
Why?
Randomized Controlled Trials as Topic
1
1996
400
0.060
Why?
Gonads
1
1993
6
0.050
Why?
Supratentorial Neoplasms
1
1993
8
0.050
Why?
Hypogonadism
1
1993
12
0.050
Why?
Multivariate Analysis
2
1990
487
0.050
Why?
Adrenal Glands
1
1993
48
0.050
Why?
Positron-Emission Tomography and Computed Tomography
1
2012
1
0.050
Why?
Semen Preservation
1
2012
2
0.050
Why?
Puberty, Delayed
1
2012
3
0.050
Why?
Procarbazine
1
2012
12
0.050
Why?
Sexual Dysfunction, Physiological
1
2012
10
0.050
Why?
Laparotomy
1
1992
35
0.050
Why?
Cryopreservation
1
2012
25
0.050
Why?
Canada
1
2012
75
0.050
Why?
Natriuretic Peptide, Brain
1
2012
10
0.050
Why?
Radiotherapy, Intensity-Modulated
1
2012
5
0.050
Why?
Acute Disease
2
2000
570
0.050
Why?
Radiotherapy, Conformal
1
2012
18
0.050
Why?
Confounding Factors (Epidemiology)
1
2012
59
0.050
Why?
Confidence Intervals
1
2012
155
0.050
Why?
Kaplan-Meier Estimate
1
2012
190
0.050
Why?
Age of Onset
1
2012
120
0.050
Why?
Parathyroid Hormone-Related Protein
2
2001
85
0.050
Why?
Heart Block
1
2012
55
0.050
Why?
Cholesterol
1
2012
130
0.050
Why?
Matched-Pair Analysis
1
2011
17
0.050
Why?
Outcome and Process Assessment (Health Care)
1
1992
74
0.050
Why?
Testosterone
1
2012
151
0.050
Why?
Tumor Stem Cell Assay
1
1991
22
0.050
Why?
Carcinoma, Lobular
1
2011
24
0.050
Why?
C-Reactive Protein
1
2012
118
0.050
Why?
Pancytopenia
1
2010
13
0.050
Why?
Maximum Tolerated Dose
1
2010
16
0.050
Why?
Melphalan
1
2010
27
0.050
Why?
Lymph Nodes
1
1992
207
0.050
Why?
Mucositis
1
2010
13
0.050
Why?
Peripheral Blood Stem Cell Transplantation
1
2010
20
0.050
Why?
Granulocytes
1
1991
80
0.050
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2011
39
0.050
Why?
Polymorphism, Genetic
1
2012
191
0.050
Why?
Paresthesia
1
2010
18
0.040
Why?
Colorectal Neoplasms
1
2012
138
0.040
Why?
Genome-Wide Association Study
1
2010
22
0.040
Why?
Renal Insufficiency
1
2010
20
0.040
Why?
Radioactive Fallout
1
2010
2
0.040
Why?
Pericarditis
1
2010
10
0.040
Why?
Coronary Circulation
1
1990
89
0.040
Why?
Peptide Fragments
1
2012
277
0.040
Why?
Injections, Spinal
1
1990
23
0.040
Why?
Societies, Medical
1
2011
132
0.040
Why?
Employment
1
2010
62
0.040
Why?
Hypertrophy
1
2010
60
0.040
Why?
Arrhythmias, Cardiac
1
2012
224
0.040
Why?
Stroke
1
2012
134
0.040
Why?
Postoperative Complications
2
1992
706
0.040
Why?
Adipose Tissue
1
2010
125
0.040
Why?
Prednisolone
1
2009
24
0.040
Why?
Organ Specificity
1
2010
158
0.040
Why?
Pulmonary Fibrosis
1
2010
130
0.040
Why?
Forecasting
1
2010
172
0.040
Why?
Atrial Fibrillation
1
2010
110
0.040
Why?
Body Mass Index
1
2010
207
0.040
Why?
Translational Medical Research
1
2009
36
0.040
Why?
Disease Progression
1
2011
496
0.040
Why?
Biological Markers
1
2012
532
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2001
513
0.040
Why?
Radiobiology
1
2008
9
0.040
Why?
Proteins
2
2001
435
0.040
Why?
Occupational Exposure
1
2010
110
0.040
Why?
Rats
2
1981
4185
0.040
Why?
Radiation Injuries, Experimental
1
1988
82
0.040
Why?
Cognition
1
2010
216
0.040
Why?
Spinal Cord
1
1988
153
0.040
Why?
Leukemia, Radiation-Induced
1
2007
11
0.040
Why?
Palliative Care
2
1985
151
0.040
Why?
Topoisomerase II Inhibitors
1
2007
8
0.040
Why?
Antineoplastic Agents, Alkylating
1
2007
38
0.040
Why?
Time
1
2007
44
0.040
Why?
Meningeal Neoplasms
1
1987
46
0.040
Why?
Meningioma
1
1987
52
0.030
Why?
Osteosarcoma
1
2007
61
0.030
Why?
Reference Values
1
2007
427
0.030
Why?
Mice, Inbred C57BL
1
1991
1613
0.030
Why?
Italy
1
2005
22
0.030
Why?
Radiation-Sensitizing Agents
2
1982
72
0.030
Why?
Sarcoma, Ewing
1
1985
8
0.030
Why?
Wilms Tumor
1
1985
10
0.030
Why?
Antigens, Neoplasm
1
1986
105
0.030
Why?
Nursing Care
1
2004
11
0.030
Why?
Congenital Abnormalities
1
1985
33
0.030
Why?
Enzyme Inhibitors
1
2007
396
0.030
Why?
Skin Physiological Phenomena
2
1973
19
0.030
Why?
RNA, Messenger
2
2001
1791
0.030
Why?
Thyroxine
1
1984
43
0.030
Why?
Joints
2
1973
56
0.030
Why?
Kidney Neoplasms
1
1985
101
0.030
Why?
Cell Separation
1
1984
224
0.030
Why?
Longitudinal Studies
1
2004
372
0.030
Why?
Nitroimidazoles
1
1982
11
0.030
Why?
Neck
1
1982
34
0.020
Why?
Genes, bcl-2
1
2002
21
0.020
Why?
Research Design
1
2004
326
0.020
Why?
Chick Embryo
1
2002
158
0.020
Why?
Drug Evaluation, Preclinical
1
2002
72
0.020
Why?
Receptors, Parathyroid Hormone
1
2001
13
0.020
Why?
Receptor, Parathyroid Hormone, Type 1
1
2001
22
0.020
Why?
Cytosol
1
2002
186
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2002
110
0.020
Why?
Sodium Pertechnetate Tc 99m
1
2000
9
0.020
Why?
Chickens
1
2001
276
0.020
Why?
Radiopharmaceuticals
1
2000
48
0.020
Why?
Myeloablative Agonists
1
2000
6
0.020
Why?
Nuclear Family
1
2000
13
0.020
Why?
Drug Toxicity
1
2000
14
0.020
Why?
Drug Evaluation
1
2000
98
0.020
Why?
Protein Biosynthesis
1
2002
257
0.020
Why?
Blood Grouping and Crossmatching
1
2000
32
0.020
Why?
DNA Primers
1
2001
401
0.020
Why?
Anemia, Aplastic
1
1999
25
0.020
Why?
Wiskott-Aldrich Syndrome
1
1999
9
0.020
Why?
Life Tables
1
1999
35
0.020
Why?
Gestational Age
1
1981
334
0.020
Why?
Fetus
1
1981
256
0.020
Why?
Graft Survival
1
2000
145
0.020
Why?
Diarrhea
1
1999
61
0.020
Why?
Cell Division
1
2002
735
0.020
Why?
Hematologic Neoplasms
1
1999
34
0.020
Why?
Lymphotoxin-alpha
1
1998
13
0.020
Why?
Laser-Doppler Flowmetry
1
1998
16
0.020
Why?
Carcinoma
1
2000
188
0.020
Why?
Drug Therapy, Combination
1
1999
375
0.020
Why?
Mice, Inbred BALB C
3
1982
616
0.020
Why?
Mice, Inbred C3H
1
1998
225
0.020
Why?
Regional Blood Flow
1
1998
178
0.020
Why?
Neoplasm, Residual
1
1997
21
0.020
Why?
Base Sequence
1
2001
1681
0.020
Why?
Pilot Projects
2
1985
426
0.020
Why?
Karnofsky Performance Status
1
1996
15
0.020
Why?
Information Systems
1
1996
16
0.020
Why?
Movement
2
1973
162
0.020
Why?
Hematopoietic Cell Growth Factors
1
1995
14
0.020
Why?
Bone Marrow Diseases
1
1995
38
0.020
Why?
Calcium
1
2002
1069
0.020
Why?
Fluorescent Antibody Technique
2
1985
287
0.020
Why?
Dogs
1
1995
465
0.010
Why?
Terminology as Topic
1
1995
104
0.010
Why?
Tumor Necrosis Factor-alpha
1
1998
627
0.010
Why?
Immunoglobulin G
2
1985
491
0.010
Why?
Gallium Radioisotopes
1
1992
8
0.010
Why?
Evaluation Studies as Topic
1
1992
240
0.010
Why?
Neoplasm Invasiveness
1
1992
150
0.010
Why?
Postoperative Period
1
1992
78
0.010
Why?
Biopsy
1
1992
359
0.010
Why?
Spleen
1
1992
338
0.010
Why?
Vinblastine
1
1990
27
0.010
Why?
Dacarbazine
1
1990
17
0.010
Why?
Surgical Procedures, Operative
1
1992
108
0.010
Why?
Heart Function Tests
1
1990
29
0.010
Why?
Drug Administration Schedule
1
1990
362
0.010
Why?
Sensitivity and Specificity
1
1992
866
0.010
Why?
Electrocardiography
1
1993
719
0.010
Why?
Liver
1
1992
870
0.010
Why?
Hybridomas
1
1986
65
0.010
Why?
Antigen-Antibody Complex
1
1986
56
0.010
Why?
Premedication
1
1985
18
0.010
Why?
Carcinoma, Small Cell
1
1985
33
0.010
Why?
Myeloma Proteins
1
1985
12
0.010
Why?
Urinary Tract
1
1985
8
0.010
Why?
Binding Sites, Antibody
1
1985
33
0.010
Why?
Antibody-Dependent Cell Cytotoxicity
1
1985
28
0.010
Why?
Centrifugation
1
1984
45
0.010
Why?
Erythrocyte Count
1
1984
25
0.010
Why?
Skinfold Thickness
2
1973
7
0.010
Why?
London
2
1973
19
0.010
Why?
Complement System Proteins
1
1985
114
0.010
Why?
Leukocyte Count
1
1984
152
0.010
Why?
Elasticity
2
1973
84
0.010
Why?
Immunoenzyme Techniques
1
1985
220
0.010
Why?
Lung
1
1990
1132
0.010
Why?
Central Nervous System
1
1985
110
0.010
Why?
Bone Marrow Cells
1
1985
220
0.010
Why?
Cell Survival
1
1985
537
0.010
Why?
Etanidazole
1
1982
24
0.010
Why?
Chemistry, Pharmaceutical
1
1982
21
0.010
Why?
Injections, Intravenous
1
1982
125
0.010
Why?
Administration, Oral
1
1982
302
0.010
Why?
Cell Line
1
1986
1554
0.010
Why?
Kinetics
1
1982
1377
0.000
Why?
Metacarpus
1
1975
4
0.000
Why?
Elbow
1
1975
15
0.000
Why?
Knee
1
1975
22
0.000
Why?
Ankle
1
1975
21
0.000
Why?
Finger Joint
1
1975
23
0.000
Why?
Wrist
1
1975
49
0.000
Why?

Visualizations


Constine's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department